510(k) K080618
K080618 is an FDA 510(k) premarket notification submitted by Jas Diagnostics, Inc. for the device "DIRECT HBA1C, FRUCTOSAMINE, GLUCOSE OXIDASE LIQUID". The FDA issued a decision of Substantially Equivalent on May 23, 2008. The device falls under product code LCP (Assay, Glycosylated Hemoglobin), a Class II device regulated under 21 CFR 864.7470. Jas Diagnostics, Inc. has 19 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 23, 2008
- Date Received
- Mar 5, 2008
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Assay, Glycosylated Hemoglobin
- Device Class
- Class II
- Regulation Number
- 864.7470
- Review Panel
- HE
- Submission Type
- 510(k)
Need the full FDA record for Jas Diagnostics, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.